Back to Search
Start Over
Disturbed hippocampal histidine metabolism contributes to cognitive impairment induced by recurrent nonsevere hypoglycemia in diabetes.
- Source :
-
Biochemical & Biophysical Research Communications . Nov2023, Vol. 682, p325-334. 10p. - Publication Year :
- 2023
-
Abstract
- Hypoglycemia is a common adverse reaction to glucose-lowering treatment. Diabetes mellitus (DM) combined with recurrent nonsevere hypoglycemia (RH) can accelerate cognitive decline. Currently, the metabolic pattern changes in cognition-related brain regions caused by this combined effect of DM and RH (DR) remain unclear. In this study, we first characterized the metabolic profiles of the hippocampus in mice exposed to DR using non-targeted metabolomic platforms. Our results showed that DR induced a unique metabolic pattern in the hippocampus, and several significant differences in metabolite levels belonging to the histidine metabolism pathway were discovered. Based on these findings, in the follow-up experiment, we found that histidine treatment could attenuate the cognitive impairment and rescue the neuronal and synaptic damage induced by DR in the hippocampus, which are closely related to ameliorated mitochondrial injury. These findings provide new insights into the metabolic mechanisms of the hippocampus in the progression of DR, and l -histidine supplementation may be a potential metabolic therapy in the future. • Found novel metabolic changes of recurrent nonsevere hypoglycemia in diabetic mice. • New metabolic changes may have some impact on cognitive function in diabetic mice. • Histidine treatment may have neuroprotective effects in diabetic mice. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 0006291X
- Volume :
- 682
- Database :
- Academic Search Index
- Journal :
- Biochemical & Biophysical Research Communications
- Publication Type :
- Academic Journal
- Accession number :
- 173117215
- Full Text :
- https://doi.org/10.1016/j.bbrc.2023.10.036